Neosoma Incorporates Wholly-Owned Swiss Subsidiary
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the incorporation of a wholly-owned subsidiary
🚀 The future of AI is already unfolding:
– AI Agents = Digital employees
– Copilots in every app
– Multimodal: text, video, audio, code
– Personalized LLMs
– Edge AI on your phone
– Synthetic media boom
– Regulated & explainable
– AI x Science = 🚀
We’re just getting started.…
Memento
By 2026, over 80% of enterprises are expected to deploy generative AI (GenAI) apps or use GenAI APIs, transforming industries like healthcare, finance, and public services. 🚀 #AI #GenerativeAI #FutureTech
Source: Gartner